PubRank

Masja de Haas

Author PubWeight™ 39.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat 2009 1.62
2 Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 2007 1.60
3 Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: results of a prospective study. Br J Haematol 2004 1.53
4 The Bloodgen Project of the European Union, 2003-2009. Transfus Med Hemother 2009 1.36
5 FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood 2006 1.30
6 The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion 2007 1.24
7 Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. J Proteome Res 2009 1.24
8 Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion 2005 1.18
9 Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat Commun 2011 1.11
10 Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 2003 1.04
11 A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood 2013 1.03
12 Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 2010 0.99
13 Clinical applications of cell-free fetal DNA from maternal plasma. Obstet Gynecol 2004 0.98
14 C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia. Blood 2013 0.94
15 A novel flow cytometry-based platelet aggregation assay. Blood 2013 0.92
16 Report on the Fourth International Granulocyte Immunology Workshop: progress toward quality assessment. Transfusion 2002 0.90
17 Low Fcgamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus. Am J Med 2002 0.89
18 One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion 2008 0.88
19 Comprehensive genotyping for 18 blood group systems using a multiplex ligation-dependent probe amplification assay shows a high degree of accuracy. Transfusion 2013 0.88
20 Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia. Br J Haematol 2008 0.88
21 Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. Br J Haematol 2014 0.85
22 HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity. Mol Immunol 2008 0.82
23 Neonatal alloimmune neutropenia due to immunoglobulin G antibodies against human neutrophil antigen-5a. Transfusion 2010 0.82
24 Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts. Blood 2014 0.82
25 Juvenile cyclic amegakaryocytic thrombocytopenia: a novel entity. J Pediatr Hematol Oncol 2005 0.82
26 Molecular analysis of immunized Jr(a-) or Lan- patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a-) and Lan- phenotypes. Transfusion 2014 0.80
27 Will Genotyping Replace Serology in Future Routine Blood Grouping? - Opinion 5. Transfus Med Hemother 2009 0.80
28 Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion 2006 0.80
29 Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D. Transfusion 2014 0.80
30 CD Antigens 2001. Mod Pathol 2002 0.79
31 Reference: CD Antigens 2002. J Immunol 2002 0.79
32 A new bead-based human platelet antigen antibodies detection assay versus the monoclonal antibody immobilization of platelet antigens assay. Transfusion 2013 0.78
33 The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasma. Curr Opin Hematol 2011 0.78
34 RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification. Transfusion 2012 0.78
35 CD antigens 2002. Blood 2002 0.78
36 Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population. Transfusion 2014 0.77
37 Molecular analysis of the York antigen of the Knops blood group system. Transfusion 2011 0.77
38 Noninvasive prenatal blood group and HPA-1a genotyping: the current European experience. Transfusion 2013 0.76
39 Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia. Br J Haematol 2002 0.76
40 Small world - advance of microarrays: current status and future trends. Transfus Apher Sci 2007 0.76
41 Genotyping to prevent Rh disease: has the time come? Curr Opin Hematol 2017 0.75
42 [Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation]. Ned Tijdschr Geneeskd 2015 0.75